EWM
RPRX icon

Evercore Wealth Management’s Royalty Pharma RPRX Stock Holding History

Evercore Wealth Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-83,532
Closed -$3.42M – 429
2021
Q2 		$3.42M Buy
+83,532
New +$3.55M 0.06% 132

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
VCG
Vantage Consulting Group Virginia Beach, Virginia $19.7M AUM 280.87% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $4.26B AUM 5.81% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Evercore Wealth Management's RPRX Position: Q3 2021 in Review

Evercore Wealth Management sold out of Royalty Pharma (RPRX) in Q3 2021, closing a stake of 83,532 shares — an estimated $3.42M sold.

Evercore Wealth Management first reported a position in RPRX in Q2 2021 and held it in 1 quarter. The position peaked at $3.42M in Q2 2021. 232 funds tracked by Wall St. Rank hold RPRX as of Q3 2021.

  • Evercore Wealth Management reported no remaining Royalty Pharma position as of Q3 2021 after selling out during the quarter.
  • Evercore Wealth Management sold 83,532 Royalty Pharma shares in Q3 2021, an estimated $3.42M.
  • Evercore Wealth Management first reported a position in Royalty Pharma in Q2 2021 and held it in 1 quarter.
  • Evercore Wealth Management's Royalty Pharma position peaked at $3.42M in Q2 2021.
  • 232 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2021.

Based on Evercore Wealth Management's 13F filing for Q3 2021, filed 15 Nov 2021.